Lupin Limited — Updates, 12-02-2025: Incorporation

Lupin Limited's Board has approved several key measures, including the reappointments of Ms. Vinita Gupta as CEO for five more years starting May 28, 2025, and Mr. Ramesh Swaminathan as Executive Director and CFO for another five years from March 26, 2025. The company plans to transfer its Over-the-Counter Consumer Healthcare Business, contributing ₹1,482 million in revenue in FY24, to a newly incorporated wholly owned subsidiary, LUPINLIFE Consumer Healthcare Limited, for an expected consideration of ₹550 to ₹650 crore. Additionally, a new Employee Stock Option Scheme for 10 million shares will be formulated, enhancing employee incentives and aligning interests. This strategic repositioning could strengthen investor confidence given the focused growth strategy in the OTC segment while maintaining strong leadership.